Avivagen Inc. (OTCMKTS:VIVXF) Short Interest Down 16.8% in September

Avivagen Inc. (OTCMKTS:VIVXF) was the target of a large decline in short interest in September. As of September 15th, there was short interest totalling 11,900 shares, a decline of 16.8% from the August 31st total of 14,300 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is currently 39.7 days.

Avivagen Stock Up 9,900.0 %

OTCMKTS VIVXF opened at $0.00 on Monday. The company has a market capitalization of $7,769.50, a P/E ratio of 0.00 and a beta of -0.22. Avivagen has a 1-year low of $0.00 and a 1-year high of $0.01.

Avivagen Company Profile

Avivagen Inc focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr.